Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to Zoster Vaccine in RA Patients Starting Tofacitinib
NCT02147587Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tofacitinib in rheumatoid arthritis (RA), sponsored by Pfizer. Started Jun 2014; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02147587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02147587.